Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants
Seiten
2025
|
3rd edition
Elsevier - Health Sciences Division (Verlag)
978-0-323-93606-4 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-93606-4 (ISBN)
- Noch nicht erschienen (ca. Februar 2025)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as Lehne’s trusted undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Introductory chapters provide foundational content in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters focus on the drugs that you will most commonly see in clinical practice. Pharmacotherapeutic decision-making is emphasized, with Black Box Warnings and new Drug Decision Guide boxes. This edition features completely updated content with new chapters on drugs for sexual dysfunction and drugs for transgender health. It’s everything you need to be a safe and effective prescriber!
UPDATED! Content throughout reflects the latest drug information and evidence-based treatment guidelines and protocols.
NEW! Drugs for Sexual Dysfunction and Drugs for Transgender Health chapters in a newly combined Reproductive Health unit promote health equity.
NEW! Drug Decision Guide boxes for selected drugs emphasize a rational process for drug selection.
NEW! Clinical Pearls boxes highlight expert tips for rational drug prescription.
NEW! Chapter-opening Evolve links and “Top 300” drug icons throughout identify drugs that appear on the Top 300 prescribed drug list to help you focus your study time.
ENHANCED! Introductory chapters emphasize prescriber-level pharmacokinetics and pharmacodynamics content.
NEW! Coverage addresses immunizations and therapeutics (e.g., Regeneron, Resdemivir, dexamethasone) for SARS-CoV-2 infection (COVID-19).
UPDATED! Enhanced coverage of sexually transmitted infections reflects the latest evidence-based guidelines.
NEW! Drug content addresses medications for ectoparasite infestations.
Introductory chapters tailored to the specific needs of beginning prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
Carefully focused pharmacotherapeutics content reflects the drugs most commonly seen and used by primary and acute care prescribers, with an emphasis not on the first drug discovered or developed in each drug class, but on the agents most often used today.
Chapters address primary care drugs first, as appropriate, followed by acute care drugs.
Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
UNIQUE! Summary of Key Prescribing Considerations at the end of each drug chapter provides a concise summary of essential prescriber information.
Coverage of interprofessional collaboration addresses the growing global emphasis on interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.
Integrated coverage of Canadian trade names appears throughout and is highlighted with a familiar maple-leaf icon.
UPDATED! Content throughout reflects the latest drug information and evidence-based treatment guidelines and protocols.
NEW! Drugs for Sexual Dysfunction and Drugs for Transgender Health chapters in a newly combined Reproductive Health unit promote health equity.
NEW! Drug Decision Guide boxes for selected drugs emphasize a rational process for drug selection.
NEW! Clinical Pearls boxes highlight expert tips for rational drug prescription.
NEW! Chapter-opening Evolve links and “Top 300” drug icons throughout identify drugs that appear on the Top 300 prescribed drug list to help you focus your study time.
ENHANCED! Introductory chapters emphasize prescriber-level pharmacokinetics and pharmacodynamics content.
NEW! Coverage addresses immunizations and therapeutics (e.g., Regeneron, Resdemivir, dexamethasone) for SARS-CoV-2 infection (COVID-19).
UPDATED! Enhanced coverage of sexually transmitted infections reflects the latest evidence-based guidelines.
NEW! Drug content addresses medications for ectoparasite infestations.
Introductory chapters tailored to the specific needs of beginning prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
Carefully focused pharmacotherapeutics content reflects the drugs most commonly seen and used by primary and acute care prescribers, with an emphasis not on the first drug discovered or developed in each drug class, but on the agents most often used today.
Chapters address primary care drugs first, as appropriate, followed by acute care drugs.
Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
UNIQUE! Summary of Key Prescribing Considerations at the end of each drug chapter provides a concise summary of essential prescriber information.
Coverage of interprofessional collaboration addresses the growing global emphasis on interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.
Integrated coverage of Canadian trade names appears throughout and is highlighted with a familiar maple-leaf icon.
Assistant Dean for DNP Programs, College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, Colorado
UNIT I Introduction
UNIT II Basic Principles of Pharmacology
UNIT III Drug Therapy Across the Life Span
UNIT IV Peripheral Nervous System Drugs
UNIT V Central Nervous System Drugs
UNIT VI Drugs for Pain
UNIT VII Psychotherapeutic Drugs
UNIT VIII Substance Use Disorders
UNIT IX Drugs That Affect the Heart, Blood Vessels, Blood, and Blood Volume
UNIT X Drugs for Endocrine Disorders
UNIT XI Reproductive Health
UNIT XII Antiinflammatory, Antiallergic, and Immunologic Drugs
UNIT XIII Drugs for Bone and Joint Disorders
UNIT XIV Respiratory Tract Drugs
UNIT XV Gastrointestinal Drugs
UNIT XVI Nutrition and Complementary Therapies
UNIT XVII Therapy for Infectious and Parasitic Diseases
UNIT XVIII Cancer Therapy
UNIT XIX Drugs for Eyes, Ears, and Skin
UNIT XX Drug Therapy in Acute Care
| Erscheint lt. Verlag | 3.2.2025 |
|---|---|
| Verlagsort | Philadelphia |
| Sprache | englisch |
| Maße | 216 x 276 mm |
| Gewicht | 450 g |
| Themenwelt | Medizin / Pharmazie ► Pflege |
| ISBN-10 | 0-323-93606-7 / 0323936067 |
| ISBN-13 | 978-0-323-93606-4 / 9780323936064 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Anregungen für kreatives Handeln
Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 33,55
nach Expertenstandards, MD-Kriterien des neuen BI und Indikatoren der …
Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 39,95
Training und Transfer Pflege, Heft 3 (Print inkl. eLehrmittel)
Buch | Softcover (2023)
hep verlag
CHF 29,00
